diagnosis was non-ST-segment elevation myocardial infarction. His past medical history included essential hypertension, aortic stenosis, heart failure with preserved ejection fraction, and chronic kidney disease.
INTRODUCTION
There is a lack of data that can help guide decisions regarding incidental findings of PFO during CABG surgery in this patient population. Certainly, the benefit versus risk equation seems to be a reasonable approach on an individualized basis. We present a case where perioperative PFO closure provided an effective approach in the postoperative period when associated complications arose and warranted consideration of postoperative closure.
CASE REPORT
An 83-year-old man was admitted to our institution with the chief concern of worsening dyspnea on exertion for 3 days. The clinical
The patient underwent urgent sternotomy and 4-vessel coronary artery bypass graft (CABG) surgery with no intervention to the aortic valve because the history of the present illness was directly related to the CAD. The patient had a myocardial infarction, the aortic stenosis was graded as moderate, the patient denied aortic stenosis related symptoms prior to his admission to the hospital, and his wishes on valve replacement were not discussed with him prior to the procedure. General anesthesia was maintained without major intraoperative events. Moderate tricuspid regurgitation and a patent foramen ovale (PFO) were identified with color flow Doppler during routine transesophageal echocardiogram (TEE) prior to cardiopulmonary bypass (CPB). The decision was made to defer closure of the PFO since there was no major evidence of cardiac right-to-left shunt in the setting of general anesthesia and CPB. Pre-CPB was reported as follows: pH = 7.36; PaO 2 = 292; PaCO 2 = 41.5; HCO 3 = 23.9; base excess (BE) = −1 while administering oxygen to a fraction of inspired oxygen (FIO 2 ) of 0.9. The aortic cross-clamp time and pump time were 72 min and 90 min, respectively. Repeat TEE following CPB, however, revealed a 4.7-mm PFO and right-to-left shunting [ Figure 1 ] with normal left ventricular function and moderate RV dysfunction. Post-CPB was reported as follows, pH = 7.31; PaO 2 = 82; PaCO 2 = 42; HCO 3 = 21; BE = −5 (while administering oxygen to a FIO 2 of 1.0). There was no evidence of common causes of hypoxemia such as increased pulmonary secretions and mucus plug, bronchospasm -V/Q mismatch or insufficient FIO 2 . Further, the pulse oximetry readings were between 88% and 96% after CPB. However, there was a continuous improvement in these oximetry readings, so it remained over 95% before the patient was transferred to the Intensive Care Unit (ICU).
After 2 h of admission to the ICU, the patient became hypoxemic. A chest X-ray-film revealed low lung volumes with atelectasis, consolidation, pulmonary edema or pneumothorax. An urgent TEE was performed at the bedside since the patient had persistent hypoxemia. The TEE confirmed the presence of the PFO with significant right-to-left shunting by color Doppler mapping and unchanged moderate RV systolic dysfunction (in comparison to post-CPB TEE exam). No new wall motion abnormalities were found.
During his first 72 h of ICU stay, the patient continued to require an FIO 2 of 1.0 to maintain a PaO 2 between 50 mmHg and 65 mmHg. On postoperative day 6, the patient presented acute motor deficit in the right upper extremity. A computed tomography scan of the brain showed an ischemic stroke of the artery of Heubner territory [ Figure 2 ]. On postoperative day 7, our interventional cardiology team successfully closed the PFO with a 25-mm platzer Cribriform device AMPLATZERTM Multifenestrated Septal Occluder-"Cribiform" (Cribiform Occluder), AGA Medical corporation, Plymouth, MN, USA. [ Figure 3 ]. Immediately after the device deployment, the oxygenation increased dramatically. Indeed, he tolerated the weaning process from mechanical ventilation and was extubated 48 h after the PFO closure. Two days later, he was transferred from the ICU to the step-down unit (total length of stay in the ICU, 10 days). After being in the hospital ward for an additional week for rehabilitation, the patient developed nosocomial pneumonia, and his family decided to adopt a palliative approach to his care. The patient was, therefore, not re-admitted to the ICU at this time, and he died 4 days later.
DISCUSSION
The present case raises the question of whether deferred postoperative percutaneous closure of an incidental PFO during CABG surgery should be an option for perioperative management of PFO related morbidity. Most cardiac surgeons make decisions regarding intraoperative PFO closure on the basis of PFO size and the patient's history of embolism. The decision to defer the closure of a PFO exposes the patient to unclear immediate and long-term consequences, including postoperative refractory hypoxemia and potential ischemic stroke, [1, 2] as noted in this case.
A recent publication reported no association of PFO with increased perioperative morbidity. [3] Rather, the investigators suggested that surgical closure may increase postoperative stroke risk. In a national survey of 734 cardiac surgeons, 303 (69.2%) of 438 respondents had never observed PFO-related hypoxemia that mandated medical intervention in the immediate postoperative period and only a third of the surgeons answered that they always close a PFO during on-pump surgery. [4] Intrapulmonary shunting and ventilation-perfusion mismatch are the most common causes of hypoxemic acute respiratory failure. However, the presence of a PFO may complicate ventilatory support and perpetuate the degree of hypoxemia among patients with severe respiratory failure. [5] We thought that refractory postoperative hypoxemia was the main clinical decision-making factor for performing a rescue percutaneous PFO closure with the additional goal of reducing the risk of further cerebral embolic events.
Timing and oxygenation threshold prior to PFO closure in the perioperative setting are factors to be considered. In our case, given the stability of the hypoxemia and the tenuous RV dysfunction, we initially strived to improve his oxygenation with very aggressive medical and ventilator management until hemodynamic stability could be achieved. The occurrence of a possible cardio-embolic stroke was an additional factor to take into account for the final decision to close the PFO.
Complicating decisions, intraoperative closure of a PFO could be utilized postoperatively via a percutaneous closure if compelling indications evolve. This raises the valid question of whether the two techniques for PFO closure yield similar results. There is no compelling evidence that either approach is effective at reducing the rate of recurrent thromboembolic events when used on a routine basis. Furthermore, there are no well-designed studies that support this procedure as a secondary prevention of stroke. [6] Two recent publications showed no significant improvement in outcome associated with the closure of PFO in adults who previously had a cryptogenic ischemic stroke. [7, 8] Despite the lack of evidence to support routine closure of intraoperatively diagnosed PFO, circumstances occasionally arise in which such an intervention may be merited. Sukernik et al. [9] have published a case that shows a potential postoperative paradoxical embolism in a patient who did not undergo repair of an intraoperatively diagnosed asymptomatic PFO. The recent development of percutaneous methods of PFO closure provides an effective approach to such cases in which PFO is not closed during surgery and when postoperative hypoxemia due to right-to-left shunting or other complications, such as cardio-embolic stroke, may warrant consideration of postoperative closure. [10] 
